You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy

 

Online download statistics by month:

Online download statistics by month: June 2022 to March 2024

AbstractFullPdf
Jun 2022780813311
Jul 202230831091
Aug 202225726290
Sep 202227828187
Oct 202225125569
Nov 202220920958
Dec 202219219249
Jan 202316016060
Feb 2023126130101
Mar 2023909052
Apr 2023929239
May 2023787948
Jun 2023646426
Jul 202311811889
Aug 2023666620
Sep 2023616527
Oct 2023626825
Nov 2023616526
Dec 2023484817
Jan 2024616337
Feb 2024555538
Mar 2024838377
Total350035681437